NEVA SCHMELZER: Open Payments
NPI 1063815769 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,371 in 97 payments from 19 companies in 2025. Trend: 2023 $1,581 · 2024 $2,146 · 2025 $2,371
Food & beverage: $2,363Education: $8
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $295 |
| Shockwave Medical, Inc | 2 | $285 |
| PFIZER INC. | 12 | $229 |
| Novo Nordisk Inc | 7 | $228 |
| Amgen Inc. | 13 | $223 |
| Boston Scientific Corporation | 3 | $201 |
| E.R. Squibb & Sons, L.L.C. | 8 | $153 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94 |
| Merck Sharp & Dohme LLC | 4 | $84 |
Products named: LEQVIO, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, REPATHA, General - Vascular Intervention, ELIQUIS, CAMZYOS, Wegovy, LifeVest.
Industry payments across TX — which companies pay providers there.
